DTx West Agenda

DTx West is going virtual. Working with industry leaders, we are providing even more high-quality learning and networking opportunities than usual, but this time, through a truly interactive virtual experience.

Through a more personalized and flexible experience, attendees will be able to participate in live polls, take part in roundtables, instantly message fellow attendees, join a variety of networking sessions and much more. Oh, and not to mention the rockstar speaker faculty and crucial topics on the agenda.

With the recent changes in healthcare, it is now more crucial than ever to accelerate digital therapeutics into the hands of patients.

Download the Agenda

Conference Day 1: Workshops

  • Workshop 1 - The Digital Therapeutics Payer Masterclass
  • Workshop 2 - Telehealth & Digital Therapeutics Masterclass
Workshop 1 - The Digital Therapeutics Payer Masterclass

Workshop Leaders:

Theresa Juday, Director, Speciality Innovation, CVS Caremark

Ryan Lawton, Chief Architect, Customer Experience & Engagement, Blue Shield of California

8:00am PST | 11:00am EST

Presentation: What do Digital Therapeutics Really Mean to Payers?

  • A brief overview of the where digital therapeutics and payers have previously crossed paths
  • A discussion into where payers believe the true value of digital therapeutics lie
  • A look into how best to approach and work with payers for mutual benefit
8:30am PST | 11:30am EST

Breakout Discussions

Splitting into smaller groups, you will discuss the in’s and out’s of how payers and DTx companies can partner for mutual success. Make notes on the virtual platform for all members of the group to contribute to, on the following:

  • What do payers look for when evaluating potential digital therapeutics partners?
  • As a DTx company, what evidence should I be providing to best demonstrate my value?
  • What does a good DTx / Payers partnership look like?
  • How can payers aid with patient adoption, adherence, and product scalability?
  • What can we do in a DTx / payer partnership to help break the mold and accelerate digital therapeutics into the modern healthcare system?
9:30am PST | 12:30am EST

Life Admin Break

Go and grab a coffee, have a stretch, and let the dog out. We’ll be starting up again in 30 minutes. 

10:00am PST | 1:00pm EST

Feedback Session

Representative(s) from each group will be invited onto the virtual “stage” to share the main points from their discussion to the whole group. Additional questions from moderators and other group members, via interactive polls, will be raised during this collaborative discussion. Summary thoughts will then be shared by the moderator(s) and all participants will leave with the below:

 

Leave this workshop with:
  • A deeper understanding of how-to initially approach and work with payers 
  • Up-to-date information what payers are looking for from digital therapeutics companies to consider working together
  • An understanding of how to demonstrate your value to payers effectively and efficiently
  • A clear understanding of the payer landscape and their mindsets
  • Your questions answered by industry leaders and your peers
11:00am PST | 2:00pm EST

End of Workshop 1

Download Agenda
Workshop 2 - Telehealth & Digital Therapeutics Masterclass

Workshop Leader:

Berkley Nelson, VP, Commercial, Bigfoot Biomedical

Antoun Nabhan, VP, Commercial Development, Pear Therapeutics

12:00am PST | 3:00pm EST

Presentation: How telehealth and DTx can fill the requirement for remote patient care?

  • A Brief overview of the where DTx and telehealth are carving out their place within the healthcare system
  • A discussion on why options for remote patient care is at an all-time high
  • A look at when we could be seeing DTx and Telehealth used regularly alongside traditional therapeutics
12:30am PST | 3:30pm EST

Breakout Discussions

Splitting into smaller groups, you will discuss the in’s and out’s of where the opportunities for digital therapeutics and telehealth truly lie within the world of healthcare and how far this can continue to grow. Make notes on the virtual platform for all members of the group to contribute to, on the following:

  • How can digital therapeutics and telehealth disrupt the current healthcare system for improved patient care and outcomes?
  • Has the global pandemic opened the door for remote patient care solutions to really scale up?
  • Where are some current success stories in the industry and what can we learn from them?
  • How do digital therapeutics companies and telehealth need to think differently to improve adoption?
  • What can we learn from other areas of digital health?
1:30pm PST | 4:30pm EST

Life Admin Break

Go and grab a coffee, have a stretch and let the dog out. We’ll be starting up again at 3pm!

2:00pm PST | 5:00pm EST

Feedback Session

Representative(s) from each group will be invited onto the virtual “stage” to share the main points from their discussion to the whole group. Additional questions from moderators and other group members, via interactive polls, will be raised during this collaborative discussion. Summary thoughts will then be shared by the moderator(s) and all participants will leave with the below:

Leave this workshop with:
  • A clear understanding of the industry of remote patient care
  • A deeper understanding of how telehealth and digital therapeutics can fill the need for remote care
  • An understanding of how the implementation of remote care at scale with have an effect on the wider healthcare industry
  • Being in the know for what this industry could grow to if implementation is executed at scale
  • Your questions answered by industry-leading experts and your peers
3:00pm PST | 6:00pm EST

End of Workshop 2

Download Agenda

Conference Day 2

  • Wednesday February 24th
Wednesday February 24th
7:00am PST | 10:00am EST

Conference Platform Opens

The conference platform opens before the agenda starts, giving you time to plug the presentations, panels and discussions into your agenda for the rest of the day. This also gives you plenty of time to get familiar with the platform.

8:00am PST | 11:00am EST

Chairs Opening Remarks and Setting the Scene

Sarah Jackson, Chief of Staff, Click Therapeutics

8:05am PST | 11:05am EST

Keynote Presentation: A Working DTx and Payer Relationship

Over the past year, all eyes have been on the digital therapeutics industry including that of payers. This fireside chat will put the relationship between Welldoc & CVS Health under the microscope, understanding how the partnership began, how both companies are both benefiting and their plans for the future.

Anand Iyer, Chief Strategy Officer,Welldoc

Kenneth Snow, Medical Director, CVS Health

8:35am PST | 11:35am EST

Wellness Break

Get-up and have a stretch before the next session begins.

8:40am PST | 11:40pm EST

Keynote Panel Discussion: How are Digital Therapeutics Going to Change the Healthcare Industry Globally?

Hear from the pioneers and leaders of the digital healthcare space who are making the first strides into making digital therapeutics a mainstream in modern medicine. This panel, made up of leaders from across the globe, will discuss who digital therapeutics has the capabilities to change healthcare across the world.

  • What can digital therapeutics provide to the current healthcare climate to improve patient care and outcomes?
  • After such exponential advances over the past year, how can we ensure we keep driving forward as an industry?
  • Where have we seen successful integration of digital into a healthcare system and how can we learn from this?
  • What other industries can we learn from?
  • What is holding digital therapeutics back from global healthcare success?

Dr. Gottfried Ludewig, Head of Division 5, Digitalisation & Innovation, German Federal Ministry of Health

Louise Schaper, Chief Executive Officer, Australasian Institute of Digital Health

Bakul Patel, Director, Division of Digital Health & Director, Digital Health Center of Excellence, FDA

Megan Coder, Executive Director, Digital Therapeutics Alliance

Saeju Jeong, Co-Founder & CEO, Noom

9:10am PST | 12:10 EST

Optional Break

Catch-up on emails, let the dog out, brew some more coffee… use this time to take care of regular day-to-day life.


 

9:10am PST | 12:10 EST

Keynote Panel Discussion Q&A

Use this time to ask questions of the members of the panel discussion. This is your opportunity to really ask those who are leading the charge at changing the healthcare systems the most pressing questions.

Dr. Gottfried Ludewig, Head of Division 5, Digitalisation & Innovation, German Federal Ministry of Health

Louise Schaper, Chief Executive Officer, Australasian Institute of Digital Health

Bakul Patel, Director, Division of Digital Health & Director, Digital Health Center of Excellence, FDA

Megan Coder, Executive Director, Digital Therapeutics Alliance

Saeju Jeong, Co-Founder & CEO, Noom


 

9:30am PST | 12:30pm EST

Wellness Break

Get-up and have a stretch before the next session begins.

9:35am PST | 12:35pm ET

Fireside Chat: A sit-down with Pear Therapeutics and Several of Its Early Payer Partners

In 2020, we’ve seen a number of huge announcements around digital therapeutics reimbursement and Pear Therapeutics has been the center of this exciting news more than most. This session, involving the catalysts and deal-makers themselves, will deep dive into the whys and hows these partnerships came into fruition and what awesome looks like moving forward.

Michael Pace, VP, Market Access, Value & Evidence, Pear Therapeutics

Samir Mistry, VP, Pharmacy, Preferred One

Katie Archer, Director, Health and Welfare Plans Benefits Design, Planning and Analysis, The Hartford Financial Services Group, Inc.

Renee Wallace, Clinical Pharmacist, Serve You Rx

10:25am PST | 1:25pm EST

Wellness Break

Get-up and have a stretch before the next session begins.

Location: Sessions

10:30am PST | 1:30pm EST

Presentation: An Akili Interactive Case Study – The FDA has Entered the Game

Having been leaders of the industry since the industry began, Akili have recently received FDA approval for the world’s first prescription video game therapeutic, EndeavorRx. This is how it happened.

  • An insight into Akili’s vision from development to FDA approval
  • A discussion regarding Akili’s journey working with the FDA
  • What’s next for Akili Interactive?

Eddie Martucci, Chief Executive Officer, Akili Interactive

Location: Stage

10:30am PST | 1:30pm EST

Presentation: The 5 Biggest Mistakes I’ve Made in 2020

With digital therapeutics trending moving from strength to strength, it’s easy to see that the industry is making the right moves for success. However, this open and honest presentation will dive into the few times a leading DTx company made mistakes and the lessons they learned from them

  • An in-depth discussion on the top 5 mistakes Woebot Health made during 2020
  • A look into how Woebot turned these mistakes into positive learning experiences
  • A lasting statement on how best you can learn from your mistakes in an emerging industry

Athena Robinson, Chief Clinical Officer, Woebot Health

10:55am PST | 1:55pm EST

Lunch

Finally, a conference lunch that is entirely your choice!

Use this extended break to stretch your legs, grab some food and recharge.

Day 2 of DTx West includes an extended break in the middle to give you ample time for lunch and another chance to catch-up on the day job. Or if you have time, you can use this break for 1-2-1 meetings or open networking.

DTx West will now split into two tracks.

Personalize your experience by hopping in and out of sessions and meetings seamlessly, or spend time in the Networking area.

Track 1 - Crucial Case Studies

1:00pm PST | 4:00pm EST

Presentation by Cognoa

Hear from some of the top names in the space regarding their new pivotal trial data and recent submission to the FDA. Years in the making, this is not to be missed.

  • An insight into Cognoa’s new pivotal trial data
  • An overview of Cognoa’s workings with the FDA during their recent submission
  • What’s next for Cognoa?

Sharief Taraman, Chief Medical Officer, Cognoa


1:30pm PST | 4:30pm EST

Wellness Break

Get-up and have a stretch before the next session begins.


1:35pm PST | 4:35pm EST

Presentation: An Deep-Dive into Biofourmis’ Unique Commercial Model

With the healthcare system ready for remote care to take its place alongside traditional drugs and the industry flooded with great solutions, how can you best demonstrate your value in your product to potential partners?

  • A deep dive into the work Biofourmis are doing
  • A look at the unique modelBiofourmis have developed for commercial success
  • What are the future plans for Biofourmis?

Kuldeep Singh Rajput, Founder & CEO, Biofourmis


2:00pm PST | 5:00pm EST

Wellness Break

Get-up and have a stretch before the next session begins.


2:05pm PST | 5:05pm EST

Presentation: Creating THE Universal Platform for Brain Health

  • The vision for the “universal platform for brain health”
  • The next frontier in neuro-care – Overview of our digital therapeutics that are in different stages of early to advanced research and development 
  • A look at the future of neuro-digital therapeutics as a whole, including what’s next for regulations

John Krakauer, Chief Medical and Scientific Advisor, MindMaze


 

Track 2 - Dynamic Discussions

1:00pm PST | 4:00pm EST

Panel Discussion: How do we Define Enforcement Discretion Exactly?

This interactive, discussion-led session will enable you to deepen your understanding of enforcement discretion regulation. Share your insights, pose your questions to the group or simply listen in to the conversation, the choice is yours. Kickstarter discussions include:

  • A discussion on what exactly enforcement discretion is
  • How can we ensure we are staying within the guidelines when so many are unsure of where they lie?
  • Understanding how best to work the regulatory bodies to outline exactly what is required

Acacia Parks, Chief Science Officer, Happify Health

Marisa Cruz, Chief Medical Officer, Limbix

Lucia Savage, Chief Privacy and Regulatory Officer, Omada Health

Ankur Kaushal, VP, Regulatory Affairs & Quality, Big Health

Susan Baumgartner, VP, Product Management & Regulatory Affairs, etectRx


1:40pm PST | 4:40pm EST

Wellness Break

Get-up and have a stretch before the next session begins.


1:45pm PST | 4:45pm EST

Panel Discussion: The Frontline Requirement for Remote Patient Care

Digital Therapeutics are clinically validated through vigorous trials. However, a door that is not fully unlocked yet is effective and efficient integration into clinicians workflows. The panel will dive into what frontline clinicians think of DTx and remote medicine in general.

  • What do clinicians really think of digital therapeutics? 
  • Has the recent COVID 19 pandemic changed the opinions of clinicians regarding DTx?
  • How are we working with clinicians to ensure smooth integration into their workflow?
  • What will it take to have digital therapeutics prescribed at the same rate as traditional drugs?

Raj Khandwalla, Director of Digital Therapeutics, Cedars-Sinai

Simon Lin, Chief Research Information Officer, Nationwide Children’s Hospital

Valerie Sullivan, President & CEO, etectRx

Jennifer Johns, SVP, Strategic Accounts, Propeller Health

YiDing Yu, Chief Medical Officer, Verata Health

2:30pm PST | 5:30pm EST

Wellness Break

Get-up and have a stretch before the next session begins.

Location: Sessions

2:35pm PST | 5:35pm EST

Panel Discussion: A Patient-First Perspective on Digital Therapeutics

Hear from real patients who have found themselves involved in the DTx diagnostics, therapeutics and clinical trials. This session will tell you all you need to know about what patients truly think of Digital Therapeutics, right from the horse’s mouth. 

  • A discussion on the patient’s initial thoughts when first hearing about digital therapeutics and how their perspective changed during the treatment
  • A deepdive into how the patient compare digital therapeutics with traditional drugs
  • A look into the patient’s perspective on using digital therapeutics moving forward for further treatment
  • A critical analysis of what could be improved to help better improve patient outcomes and engagement
  • An understanding of exactly how digital therapeutics are currently affecting the lives of patients

Moderated by Amir Lahav, Healthcare Intelligence Consultant, Digital Transformation and RWE, Mitsubishi Tanabe Pharma America

Sarah Cooper, Product Design,MedRhythms

Patient Representative from MedRhythms

Sharief Taraman, Chief Medical Officer, Cognoa

Patient Representative from Cognoa

Delora Denney, Patient & Clinical Support Advisor, Curelator

3:05pm PST | 6:05pm EST

Open Q&A with Speakers

Use this time to ask questions of the members of the previous discussion. Speak to the patients directly and pose them your questions to further understand the real impact digital therapeutics can have on patient care and experience.

Moderated by Amir Lahav, Healthcare Intelligence Consultant, Digital Transformation and RWE, Mitsubishi Tanabe Pharma America

Sarah Cooper, Product Design,MedRhythms

Patient Representative from MedRhythms

Sharief Taraman, Chief Medical Officer, Cognoa

Patient Representative from Cognoa

Delora Denney, Patient & Clinical Support Advisor, Curelator

3:30pm PST | 6:30pm EST

Virtual Drinks Reception

Share a virtual drink with old friends or new connections. At small virtual tables, this is your chance to casually interact with the rest of the Digital Therapeutics industry.

4:30pm PST | 7:30pm EST

End of DTx West Day 2

Download Agenda

Conference Day 3

  • Thursday February 25th
Thursday February 25th
07:00am PST | 10:00am EST

Conference platform opens

The conference platform opens before the agenda starts, giving you time to plug the presentations, panels and discussions into your agenda for the rest of the day

08:00am PST | 11:00am EST

Chairs Opening Remarks: Digital Transformation Trends to Watch in 2021 and Beyond

While some digital technologies are starting to become part of the mainstream health lexicon, there are many more still carving out their name and recognition. The next decade is sure to be the real test for the DTx revolution.

Amir Lahav, Healthcare Intelligence Consultant, Digital Transformation and RWE, Mitsubishi Tanabe Pharma America

08:20am PST | 11:20am EST

Keynote Fireside Chat: Digital Therapeutics and Pharmaceutical Partnerships – A landmark collaboration to solve for a complex disease

Click Therapeutics, a leader in digital therapeutics, and Boehringer Ingelheim, a leading global pharmaceutical company, announced one of the latest industry collaborations underlining the growing interest of big pharma in digital therapeutics and the significant value of such collaborations. Our keynote will explore this collaboration on the development and commercialization of a novel prescription digital therapeutic for the treatment of schizophrenia. We will particularly explore how the collaboration aims to make such an innovative treatment modality broadly accessible, as well as how each company is leveraging the collaboration as an opportunity to further learn and contribute in treating patients in an unprecedented way.

  • Why was this partnership, and this partner specifically, attractive to you?
  • What is your vision for the partnership?
  • How does the partnership enable each company to better address patient needs?
  • How do you hope this partnership shapes the digital therapeutics landscape?

David Klein, Chief Executive Officer, Click Therapeutics

Ross Muken, Chief Financial Officer, Click Therapeutics

Jan Stefan Scheld, Corporate Senior Vice President, Therapeutic Area Head CNS, Retinopathies & Emerging Areas, Boehringer Ingelheim

Ioannis Sapountzis, Corporate SVP & Global Head BD&L, Boehringer Ingelheim

9:00am PST | 12:00pm EST

Wellness Break

Get-up and have a stretch before the next session begins.

9:05am PST | 12:05pm EST

Keynote Panel Presentation: A Deepdive into the Payer Perspective of Digital Therapeutics 

Over the past year, there has been an increased need and demand for remote patient care. The digital therapeutics industry has stepped forward with plans to fill this demand. Much of their success depends on reimbursement and ROI from payers. This panel will put payers in the spotlight to find out exactly what they think of digital therapeutics

Theresa Juday, Director, Speciality Innovation, CVS Caremark

Michael Sherman, Chief Medical Officer, Harvard Pilgrim Healthcare

Ryan Lawton, Chief Architect, Customer Experience & Engagement, Blue Shield of California

Elizabeth Kwo, Staff Vice President, Clinical Data Analytics, Anthem

9:35am PST | 12:35pm EST

Open Q&A with Speakers 

Use this time to ask questions of the members of the panel. Ask your questions to these payers to better understand their thoughts on the digital therapeutics industry.

Theresa Juday, Director, Speciality Innovation, CVS Caremark

Michael Sherman, Chief Medical Officer, Harvard Pilgrim Healthcare

Ryan Lawton, Chief Architect, Customer Experience & Engagement, Blue Shield of California

Elizabeth Kwo, Staff Vice President, Clinical Data Analytics, Anthem

9:55am PST | 12:55pm EST

Speed Networking 

Grab yourself a coffee and head over to the Networking Area for some speed networking. Here you will be paired up with another member of the audience in a brief 1 on 1 session, learning all about those sat across from you, exchanging contact details before eventually saying farewell, and being paired up with your next industry colleague.

Your next business partner might just be one click away.

Location: Sessions

10:30am PST | 1:30pm EST

Panel Discussion: Injecting Capital into Digital Therapeutics

With all eyes on remote care solutions, DTx has really been in the spotlight this year. This panel discussion will provide an updated perspective of what investors truly think of digital therapeutics after a year of a highly accelerated industry boom

  • Since the recent pandemic, are investors more or less likely to be pulling the trigger on DTx investments?
  • How has the DTx investment landscape changed since DTx West 2020?
  • A discussion into what investors need to see from DTx companies to consider investing
  • Aside from injecting capital into the business, how can investors help DTx companies grow?
  • Where is the ceiling for digital therapeutics?

Cris De Luca, Global Head, Digital Investments, Sanofi Ventures

Yizhen Dong, Partner, Global Founders Capital

Elan Tye, Principal, JAZZ Venture Partners

Chihiro Hosoya, Head of Venture Management and Business Development, Rx+ Business Accelerator, Astellas Pharma

Raj Pallapothu, Managing Director, Bio 9 Ventures

Andrey Ostrovsky, Managing Partner, Social Innovation Partners

11:00am PST | 2:00pm EST

Open Q&A With Speakers

Use this time to ask questions of the panelists. Pose your questions to the expert investors to ensure you’re fully in-the-know when it comes to securing investment.

Cris De Luca, Global Head, Digital Investments, Sanofi Ventures

Yizhen Dong, Partner, Global Founders Capital

Elan Tye, Principal, JAZZ Venture Partners

Chihiro Hosoya, Head of Venture Management and Business Development, Rx+ Business Accelerator, Astellas Pharma

Raj Pallapothu, Managing Director, Bio 9 Ventures

Andrey Ostrovsky, Managing Partner, Social Innovation Partners

11:20am PST | 2:20pm EST

Wellness Break

Get-up and have a stretch before the next session begins.

11:25am PST | 2:25pm EST

Interactive Roundtable: How has Pharma’s mindset on DTx changed over the past year?

This interactive, discussion-led session will enable you to be fully up-to-date on how pharma views digital therapeutics. Share your insights, pose your questions to the group or simply listen in to the conversation, the choice is yours. Kickstarter discussions include:

  • Given the COVID 19 global pandemic and push for remote care, how has pharma’s view changed on digital therapeutics?
  • What will it take for digital therapeutics to be a staple in medicine alongside traditional drugs?
  • How are pharma looking to continue incorporating digital in their main pipeline efforts?

Joris Van Dam, Executive Director, Head of Digital Therapeutics, Novartis

Francesca Wutke, Chief Digital Officer, Almirall

Jacob Sunol, Chief Digital Officer, Ipsen

Suhas Krishna, Executive Director, Digital Therapeutics, Bristol Myers Squibb

Jin Lee, Director of Digital Health Product & Commercial Strategy, Astellas Pharma

11:55am PST | 2:55pm EST

Open Q&A With Speakers

Use this time to ask questions of the members of the panelists. Pose your questions to the pharma experts to fully understand how their perspective may have changed over recent months.

Joris Van Dam, Executive Director, Head of Digital Therapeutics, Novartis

Francesca Wutke, Chief Digital Officer, Almirall

Jacob Sunol, Chief Digital Officer, Ipsen

Suhas Krishna, Executive Director, Digital Therapeutics, Bristol Myers Squibb

Jin Lee, Director of Digital Health Product & Commercial Strategy, Astellas Pharma

12:15am PST | 3:15pm EST

Chairs Closing Remarks

End of DTx West 2021

Download Agenda